Dr. Pennesi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3375 SW Terwilliger Blvd
Cei
Portland, OR 97239Phone+1 503-494-8386
Education & Training
- University of PennsylvaniaBS, Bioengineering, Summa Cum Laude, 1997
- Oregon Health Science University HospitalFellowship, Ophthalmic Genetics and Inherited Retinal Degeneration, 2008 - 2009
- University of California2005 - 2008
- Scripps Mercy Hospital2005 - 2005
- Baylor College of MedicineClass of 2004
- Baylor College of MedicinePh.D, Neuroscience, 2003 - 2003
Certifications & Licensure
- CA State Medical License 2006 - Present
- TX State Medical License 2023 - 2026
- OR State Medical License 2008 - 2025
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Scientist Research Award ARVO/Alcon Early Clinician, 2011
- Travel Award International Society for Clinical Electrophysiology in Vision, 2009
- Join now to see all
Clinical Trials
- Rate of Progression in USH2A-related Retinal Degeneration Start of enrollment: 2017 Aug 11
Publications & Presentations
PubMed
- Refractive Error in Inherited Retinal Disease.Shaden H Yassin, Naomi E Wagner, Thomas Khuu, Ryan Schmidt, Austin D Igelman
American Journal of Ophthalmology. 2025-01-01 - Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results: Subretinal Gene Therapy AGTC-501 for XLRP P...Paul Yang, David Birch, Andreas Lauer, Robert Sisk, Rajiv Anand
American Journal of Ophthalmology. 2024-12-04 - Patient-reported visual function outcomes agree with visual acuity and ophthalmologist-graded scoring of visual function among patients with long-chain 3-hydroxyacylco...Ashley N Gregor, Danielle Black, Nida Wongchaisuwat, Mark E Pennesi, Melanie B Gillingham
Molecular Genetics and Metabolism Reports. 2024-12-01
Journal Articles
- Strategies for Treating Inherited Retinal Degeneration with Large Genes That Are Not Amenable to Adeno-Associated Virus–Based Gene Replacement TherapyMark E Pennesi, Richard G Weleber, JAMA Ophthalmology
- Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJoseph M Simonett, Mark E Pennesi, Nieraj Jain, JAMA Ophthalmology
- Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients with Autosomal Dominant Retinitis PigmentosaDavid G Birch, Michael P Teske, Richard G Weleber, Robert Lindblad, Byron L Lam, Judith Warner, Gary Edd Fish, Neal L Sklaver, Mark E Pennesi, John Heckenlively, Paul ..., JAMA
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Lentiviral Vector for Gene Replacement Therapy in Stargardt Disease and Usher Syndrome Type IB.Wilson D, Stout JT, Weleber RG, Pennesi ME, Francis PJ, Sahel J, Mohand-Said S, Naylor S Audo I, Macula Society, Jerusalem Israel
- Imaging the Cone Mosaic using a Commerically available Adaptive Optics Flood Illuminated Camera and Examining its Potential as an Endpoint for Clinical Trials.Pennesi ME, Fay JD, Faridi A, Garg AK, Chegarnov EN, Michaels KV, International Society for Clinical Electrophysiology in Vision, Valencia, Spain
- Hand-Held Spectral-Domain Optical Coherence Tomography in the Evaluation of Patients in a Pediatric Ophthalmic Genetics Clinic.Pennesi ME, Courtney RJ, Francis PJ, Weleber RG, International Society for Clinical Electrophysiology in Vision, Quebec City, Montreal
- Join now to see all
Lectures
- SD-OCT of Mice and Men.Coordes Conference, UCSF
- Retinitis Pigmentosa.Foundation Fighting Blindness, Visions Conference
- The Advantages of Hand-held sdOCT for Studying Retinal Degeneration in Infants and Animal Models.National Eye Institute
- Join now to see all
Authored Content
- Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020
- Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020
- Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020
Press Mentions
- CRISPR Can Treat Common Form of Inherited Blindness, Early Data HintMay 15th, 2024
- Gene Therapy Improves Vision in Leber Congenital Amaurosis PatientsMay 10th, 2024
- CRIPSR Gene Editing Leads to Improvements in Vision for People with Inherited Blindness, Clinical Trial ShowsMay 6th, 2024
- Join now to see all
Grant Support
- Serotonin Receptor Modulation Of Neurotrophic Factors In The RetinaNational Eye Institute2011–2012
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: